Literature DB >> 20801174

Enhanced transduction efficiency of fiber-substituted adenovirus vectors by the incorporation of RGD peptides in two distinct regions of the adenovirus serotype 35 fiber knob.

Hayato Matsui1, Fuminori Sakurai, Kazufumi Katayama, Shinnosuke Kurachi, Katsuhisa Tashiro, Kumiko Sugio, Kenji Kawabata, Hiroyuki Mizuguchi.   

Abstract

Fiber-substituted Ad serotype 5 vectors containing the fiber protein from Ad serotype 35 (Ad5F35) exhibit properties that render them suitable as a platform for targeted Ad vectors. Ad5F35 vectors do not show apparent tropism in certain organs, including the liver, and they elicit less innate immunity than other vectors after intravenous administration. In order to develop a targeted Ad vector, we previously developed fiber-mutant Ad5F35 vectors containing the integrin binding Arg-Gly-Asn (RGD) motif in the FG or HI loop of the Ad35 fiber knob. Mutant Ad5F35 vectors containing the RGD peptide in the FG or HI loop transduced CD46-negative cells more efficiently in an RGD-dependent manner, as compared to the efficiency achieved with unmodified Ad5F35 vectors (Matsui et al., 2009. Gene Therapy 16, 1050-1057). However, the transduction efficiency of the mutant Ad5F35 vectors in CD46-negative cells remained lower than had been expected. Ad5F35 vectors containing the RGD peptide in the HI or FG loop enabled a 6-fold higher transduction efficiency than that achieved with unmodified Ad5F35 vectors in CD46-negative cells, although this cell type abundantly expresses α(v)-integrins. In the present study, we aimed to enhance the transduction efficiency of fiber-mutant Ad5F35 vectors. To this end, we developed an Ad5F35-vector system in which foreign peptides could be incorporated into regions of FG and HI loops of the Ad35 fiber knob by means of in vitro ligation. Using this Ad5F35-vector system, firefly luciferase-expressing mutant Ad5F35 vectors containing the RGD peptides in both loops (Ad5F35-2xRGD-L2) were constructed. In CD46-negative cells, Ad5F35-2xRGD-L2 showed 12-fold and 3-fold greater transduction efficiency than unmodified Ad5F35 vectors and mutant Ad5F35 vectors containing only one copy of the RGD peptide in the FG or the HI loop. In addition, transduction with Ad5F35-2xRGD-L2 in CD46-negative cells was RGD peptide-dependent. These results indicate that fiber-mutant Ad5F35 vectors, by which foreign peptides can be simultaneously incorporated into both the FG and the HI loops of the Ad35 fiber knob, could be a promising gene delivery vehicle for various gene therapies, and could facilitate basic research efforts such as analyses of gene function.
Copyright © 2010 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20801174     DOI: 10.1016/j.virusres.2010.08.021

Source DB:  PubMed          Journal:  Virus Res        ISSN: 0168-1702            Impact factor:   3.303


  6 in total

Review 1.  A novel fiber chimeric conditionally replicative adenovirus-Ad5/F35 for tumor therapy.

Authors:  Ming Yang; Chun Sheng Yang; WenWen Guo; JianQin Tang; Qian Huang; ShouXin Feng; AiJun Jiang; XiFeng Xu; Guan Jiang; Yan Qun Liu
Journal:  Cancer Biol Ther       Date:  2017-11-16       Impact factor: 4.742

2.  Construction of a tumor cell-targeting non-viral gene delivery vector with polyethylenimine modified with RGD sequence-containing peptide.

Authors:  Hai-Bo Xing; Hong-Ming Pan; Yong Fang; Xiao-Yun Zhou; Qin Pan; DA Li
Journal:  Oncol Lett       Date:  2013-11-29       Impact factor: 2.967

3.  Efficient gene transfer into T lymphocytes by fiber-modified human adenovirus 5.

Authors:  Yun Lv; Feng-Jun Xiao; Yi Wang; Xiao-Hui Zou; Hua Wang; Hai-Yan Wang; Li-Sheng Wang; Zhuo-Zhuang Lu
Journal:  BMC Biotechnol       Date:  2019-04-24       Impact factor: 2.563

4.  An inactivated novel chimeric FAdV-4 containing fiber of FAdV-8b provides full protection against hepatitis-hydropericardium syndrome and inclusion body hepatitis.

Authors:  Baiyu Wang; Mingzhen Song; Congcong Song; Shiyi Zhao; Panpan Yang; Qilong Qiao; Yanfang Cong; Yanling Wang; Zeng Wang; Jun Zhao
Journal:  Vet Res       Date:  2022-09-30       Impact factor: 3.829

Review 5.  The evolution of adenoviral vectors through genetic and chemical surface modifications.

Authors:  Cristian Capasso; Mariangela Garofalo; Mari Hirvinen; Vincenzo Cerullo
Journal:  Viruses       Date:  2014-02-17       Impact factor: 5.048

Review 6.  Peptide-based technologies to alter adenoviral vector tropism: ways and means for systemic treatment of cancer.

Authors:  Julia Reetz; Ottmar Herchenröder; Brigitte M Pützer
Journal:  Viruses       Date:  2014-04-02       Impact factor: 5.048

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.